Carbon Biosciences

Private

Lexington, MassachusettsHealthcare & Life Scienceshttps://www.carbonbio.com/

Last Round

Series A

Jun 21, 2022

Total Funding Raised

$38M

Company Overview

Carbon Biosciences is a biotechnology company that develops genetic medicines for severe diseases using a proprietary parvovirus-based vector platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyviral vectorparvoviruscystic fibrosisgenetic medicinegene deliveryadeno-associated virusAAVcapsid engineeringbiotech startupgenetic payloaddrug discoverynext-gen gene therapypreclinical biotechtissue tropism

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Carbon Biosciences Comps

Public and private peers based on sector, stage, and business model.

Carbon Biosciences comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Carbon Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jun 21, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Joel Schneider

President and Chief Executive Officer

Executive Team

Keith Dewedoff

Chief Financial Officer

Executive Team

Carbon Biosciences Investors

Notable investors and investment history

Carbon Biosciences investors
Investor	Rounds
Agent Capital	Series A
Dean Capital Investments Management	Series A
Camford Capital	Series A
Solasta Ventures	Series A
Cystic Fibrosis Foundation	Series A
Astellas Venture Management	Series A
Camford Capital	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 21, 2022
$38M round led by Agent Capital.

View all signals

Carbon Biosciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Carbon Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Carbon Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersLexington, Massachusetts

Employee Range11

Year Founded2021

Last FundingJun 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.